SXTC • NASDAQ
China SXT Pharmaceuticals, Inc.
$0.15
Stock Details
| Market Cap | 17,520,111 |
|---|---|
| Day Change | -1.099 (-87.92%) |
| Volume | 107,564,143 |
| Avg Volume | 3,694,361 |
| Price Range | 0.142-6.98 |
Overview
| Country | CN |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | NASDAQ |
Company Profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
Financial Overview
| 52 Week High | 7.84 |
|---|---|
| 52 Week High Date | 2025-02-24 |
| 52 Week Low | 0.142 |
| 52 Week Low Date | 2026-01-09 |
| 10D Avg Trading Vol | 22.45114 |
| YTD Price Return Daily | -90.5625 |
| MTD Price Return Daily | -90.5625 |
Cash Flow
| TTM/Share | -21.29263 |
|---|---|
| Annual/Share | -0.1706 |
| Quarterly/Share | -0.1706 |
Price-to-Earnings
| Annual Ratio | 3.5423 |
|---|---|
| Quarterly Ratio | 3.5423 |
| TTM |
Revenue
| 3Y Growth | -12.51 |
|---|---|
| 5Y Growth | -19.53 |
| Annual/Share | -7.84 |
| TTM/Share | 0.7127 |
| 5Y Share Growth | -70.15 |
Earnings Per Share
| Annual | -2.3211 |
|---|---|
| 3Y Growth | |
| 5Y Growth | |
| Quarterly YOY Growth |
Price-to-Book
| Ratio | 9.3936 |
|---|---|
| Annual Ratio | 0.1168 |
| TTM | 0.1168 |